Module 4: Early In Vivo Exploratory and Derisking Studies

Recorded On: 05/07/2026

image
image


Following extensive in silico, in vitro, and ex vivo characterization of a drug candidate, the next step is often to further understand potential on-target and off-target safety risk in vivo. This presentation will review different types of exploratory studies that could be considered prior to the FIH-enabling nonclinical toxicology studies. Topics may include early targeted studies evaluating toxicities that often impact drug development, such as cardiovascular safety and hepatotoxicity, the use of exploratory studies to understand a novel mechanism of action, consideration of customized endpoints (biomarkers) in vivo based on the target.

J. Eric McDuffie, PhD

J. Eric McDuffie, PhD

Senior Scientific Director of Investigative Toxicology

Neurocrine Biosciences, Inc.

Dr. J. Eric McDuffie currently serves as the Senior Scientific Director of Investigative Toxicology at Neurocrine Biosciences, Inc. in San Diego, California. Dr. McDuffie has over 25 years of experience in the application of mechanism-based in vitro and in vivo models and related assays, as well as expertise in regulatory toxicology to enable early- and late-stage drug candidate development.

He joined Neurocrine in 2021, after a 14-year tenure at Janssen Research & Development, LLC. At Janssen, Dr. McDuffie served as Director of Mechanistic & Investigative Toxicology. Previously (2000–2007), he served as Senior Scientist/Manager of the Laboratory Core Group and later the Investigative Pathology and Immunotoxicology groups at Pfizer’s Ann Arbor and Plymouth, Michigan sites, respectively.

Dr. McDuffie earned a PhD in Pharmacology from Meharry Medical College and completed a postdoctoral research fellowship in the Department of Pathology at the University of Michigan Medical School. He has given numerous platform presentations, co-authored several peer-reviewed manuscripts, posters, book chapters, and edited multiple books.


Key:

Complete
Failed
Available
Locked
Module 4 Early In Vivo Exploratory and Derisking Studies
Module 4: Early In Vivo Exploratory and Derisking Studies, J. Eric McDuffie, PhD
Recorded 05/07/2026  |  90 minutes
Recorded 05/07/2026  |  90 minutes As part of your registration, you will have unlimited access to the module recording for 30 days. Your 30-day access period begins when you first access the recording. Once the access period begins, it cannot be reset or restarted. To receive a certificate of completion, you must watch the recording for the minimum required viewing time. Please keep the recording open while viewing, as the system tracks your viewing time during the active session. If you close your browser before meeting the minimum viewing requirement, your viewing progress may not be retained. Once you have met the viewing requirement, the module survey will become available. After completing the survey, you will be able to access and download your certificate of completion. If you have any questions, please contact ACT Headquarters at [email protected].
Survey
13 Questions
13 Questions ACT values your feedback. Please help us continue to provide high-quality educational offerings by completing this short survey. The survey will become available after you have met the minimum viewing requirement for the recording. Once you complete the survey, your certificate of completion will become available on your dashboard or for download.
Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available Your certificate of completion will become available after you have met the minimum viewing requirement and completed the module survey.